Signal #150016 · SEC 8-K

$VERA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $VERA filing catalyst

Why did $VERA trigger an AI stock catalyst alert?

$VERA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Vera Therapeutics Reports Q3 Net Product Revenue of $10.3M Following TRUTAKNA Launch, EPS at -$1.30. Key points: - First commercial revenue generated: $10.3 million net product sales for TRUTAKNA with ~700 Patient Start Forms. - Net loss widened to $93.7M or $1.30 per share versus $80.3M or $1.26 per share in Q3 prior year. - Cash and equivalents stood at $384.0M down from $714.6M.

How did $VERA stock react after the SEC filing?

After the SEC 8-K for $VERA, observed market reaction: T0 price $30.14. Past moves do not guarantee future results.

Where can I get real-time $VERA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $VERA via Telegram and the VIP Web Terminal from €10/month.

$VERA

$VERA – Vera Therapeutics Reports Q3 Net Product Revenue of $10.3M Following TRUTAKNA Launch, EPS at -$1.30

Vera Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $VERA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)

First commercial revenue generated: $10.3 million net product sales for TRUTAKNA with ~700 Patient Start Forms.
Net loss widened to $93.7M or $1.30 per share versus $80.3M or $1.26 per share in Q3 prior year.
Cash and equivalents stood at $384.0M down from $714.6M.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →